CAS RN: 885521-43-7
3-Bromo-5-chloro-1H-indazole
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260401
250mg / 1g / 5g / 25g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 885521-43-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
885521-43-7 / 3-bromo-5-chloro-2H-indazole
Standard CAS: 885521-43-7
Multi CAS: No
Basic Information
copy
CAS
885521-43-7 copy
Multi CAS
No copy
Molecular Formula
C7H4BRCLN2 copy
Molecular Weight
231.480000 copy
Exact Mass
229.924640 copy
InChI
InChI=1S/C7H4BrClN2/c8-7-5-3-4(9)1-2-6(5)10-11-7/h1-3H,(H,10,11) copy
InChIKey
IYZOMWYZWTZTEQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
48.8 copy
TPSA
28.68 copy
LogP / Solubility
WLOGP
2.98 copy
MLOGP
2.63 copy
XLogP3
3.2 copy
Consensus LogP
2.94 copy
Log S (ESOL)
-3.76 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.61 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.64 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.02 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy